Abstract
(ANDA) Application for marketing authorisation if a drug has already received approval under a previous conventional NDA (applicable for generics); important drug properties as e.g. toxicity and safety have therefore already been documented; see also abriged application, approval, accelerated approval program.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Nahler, G. (2017). A. In: Dictionary of Pharmaceutical Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-50669-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-50669-2_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50668-5
Online ISBN: 978-3-319-50669-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)